METTL3 was reported to be involved in tumorigenesis of various malignancies including gastric cancer, liver cancer, hepatoblastoma, colorectal cancer and CML, and LINC00470 was found to be a regulator of METTL3.10, 26, 27, 28, 29. Here, LINC00470 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.